SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
392.00    2.00 (0.51%)
Bid:
385.00
Ask:
399.00
Spread: 14.00 (3.636%)
Market Cap: £188.15m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Director's Shareholding

9 Aug 2011 08:37

RNS Number : 0015M
Tristel PLC
09 August 2011
 



9 August 2011

TRISTEL plc

Director's Shareholding

 

Tristel plc ("Tristel" or the "Company"), the manufacturer of infection control, contamination control and hygiene products, announces that the Company was yesterday informed that Mr Antonio Soler, Non-Executive Director, acquired 10,000 Ordinary Shares in the Company on Monday 8 August 2011 at a price of 42.4p per share. 

 

Following this transaction Mr Antonio Soler is interested in 20,000 Ordinary Shares representing 0.06% of the issued share capital of the Company. 

 

For further information, please contact:

 

Tristel PLC

Paul Swinney, Chief Executive

Liz Dixon, Finance Director

Tel: 01638 721 500

 

Walbrook PR Ltd

Tel: 020 7933 8780

Fiona Henson

Mob: 07886 335 992

fiona.henson@walbrookpr.com

Helen Westaway

Mob: 07841 917 679

helen.westaway@walbrookpr.com

finnCap

Geoff Nash/Charlotte Stranner (Corporate Finance)

Tel: 020 7600 1658

Simon Starr (Corporate Broking)

Tel: 020 7220 0516

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLIFVDTVIAIIL
Date   Source Headline
23rd Feb 20224:45 pmRNSInterim dividend confirmation
22nd Feb 202211:30 amRNSDirector/PDMR Shareholding
21st Feb 20224:40 pmRNSSecond Price Monitoring Extn
21st Feb 20224:35 pmRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSHalf-year Report
17th Feb 20223:00 pmRNSIssue of Equity
1st Feb 20227:00 amRNSConfirmation of Interim Results
13th Dec 20215:13 pmRNSResult of AGM
13th Dec 20217:00 amRNSAGM Statement and notice of results
27th Oct 20217:00 amRNSDirector/PDMR Shareholding
21st Oct 20214:39 pmRNSDirector/PDMR Shareholding
19th Oct 20215:35 pmRNSHolding(s) in Company
18th Oct 20213:50 pmRNSIssue of Equity
18th Oct 202111:59 amRNSDirector/PDMR Shareholding
18th Oct 20217:00 amRNSFinal Results
12th Oct 20215:58 pmRNSHolding(s) in Company
22nd Sep 20217:00 amRNSNotice of Results
23rd Aug 20217:00 amRNSIssue of Equity
10th Aug 20217:00 amRNSIssue of Equity
29th Jul 20216:29 pmRNSTR1: Notification of Major Holdings
21st Jul 20217:00 amRNSTrading update
9th Jul 20211:21 pmRNSIssue of Equity
24th Jun 20217:00 amRNSRegulatory approval for EPA, Canada & South Korea
8th Jun 20217:00 amRNSIssue of Equity
13th May 20213:30 pmRNSIssue of Equity
26th Apr 20213:15 pmRNSDirector/PDMR Shareholding
26th Apr 20212:06 pmRNSSecond Price Monitoring Extn
26th Apr 20212:00 pmRNSPrice Monitoring Extension
26th Apr 202111:05 amRNSSecond Price Monitoring Extn
26th Apr 202111:00 amRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSTrading Update
21st Apr 20213:00 pmRNSIssue of Equity
19th Apr 20211:00 pmRNSIssue of Equity
6th Apr 20211:00 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights
26th Mar 202110:40 amRNSIssue of Equity
4th Mar 20217:00 amRNSDirector/PDMR Shareholding
1st Mar 20215:00 pmRNSDirector/PDMR Shareholding and Issue of Equity
22nd Feb 20217:00 amRNSHalf-year Report
18th Feb 202111:15 amRNSNotice of investor presentation
15th Feb 202111:00 amRNSIssue of Equity
29th Jan 20217:00 amRNSIssue of Equity
14th Jan 20212:00 pmRNSExercise of Options
24th Dec 20207:00 amRNSDirector Appointment
15th Dec 202011:39 amRNSResult of AGM
15th Dec 20207:00 amRNSAGM Statement and notice of results
2nd Dec 20202:00 pmRNSUpdate to Executive Performance Share Plan 2021
2nd Dec 202010:30 amRNSTristel wins AIM Growth Business of the Year Award
9th Nov 20209:49 amRNSExercise of Options
2nd Nov 202010:30 amRNSQ&A update following preliminary results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.